Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-20

Clinical Trial Update: Effect of Ertugliflozin on Cardiac Function in Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ertugliflozin on cardiac function in adults with type 2 diabetes; the study completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • STEGLATRO (ertugliflozin)

Snippet

Sponsor: Soo Lim | Conditions: Type2 Diabetes, Heart Failure | Phase 3 | Status: COMPLETED | Results posted: 2024-11-20